期刊文献+

RP-HPLC法测定丁丙诺啡贴剂中药物的含量和体外释放度 被引量:2

下载PDF
导出
摘要 目的建立反相高效液相色谱法(RP-HPLC)测定丁丙诺啡贴剂的含量及体外释放度的方法。方法采用高效液相色谱法(HPLC),以十八烷基硅烷键合相硅胶为固定相,甲醇-0.02tool·L^-1的醋酸铵缓冲盐溶液为流动相,检测波长286nm,流速为1.0mL·min^-1,色谱柱柱温40℃,测定丁丙诺啡贴剂的含量及体外释放度。结果丁丙诺啡在1.0~100.0mg·L^-1浓度范围内,与峰面积呈良好的线性关系,其回归方程为A=4676C+3297(r=0.9994,n=7),日内精密度和日间精密度RSD分别为0.64%和1.32%,加样平均回收率为99.79%(RSD为1.29%,n=9),检测限和定量限分别为0.10mg·L^-123mg·L^-1品溶液稳定性较好。贴剂的含量测定结果表明贴剂的含量均匀度好,体外释放遵循Higuchi方程,Q(%)=0.200t^12-019(R^20.999)。结论该方法操作简单、方便、准确、重复性好,可用于丁丙诺啡的定量测定。
出处 《安徽医药》 CAS 2013年第10期1683-1685,共3页 Anhui Medical and Pharmaceutical Journal
  • 相关文献

参考文献14

  • 1Weiner M, Sarantopoulos C, Gordon E. Transdermal buprenorphine controls central neuropathic pain[ J ]. J Opioid Manag,2012,8 (6) : 414 -415.
  • 2Kapil RP, Cipriano A, Friedman K, et al. Once-Weekly Transdermal Buprenorphine Application Results in Sustained and Consistent Steady-State Plasma Levels[J]. J Pain Symptom Manage,2012,10 (3) :28 -35.
  • 3Cachia E, Ahmedzai SH. Transdermal opioids for cancer pain [ J ]. Curr Opin Support Palliat Care ,2011,5 (1) :15 - 19.
  • 4国家药典委员会.中国药典一部[S].附录XD.北京:化工出版社,2005.51
  • 5Wen W. Application site adverse events associated with the bu- prenorphine transdermal system:a pooled analysis [ J ]. Expert Opin Drug Saf,2013,12 ( 3 ) :309 - 319.
  • 6Ruggiero A. Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain [ J ]. Pediatr Blood Cancer,2013,60( 3 ) :433 - 437.
  • 7Miller K. Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain [ J ]. Expert Opin Pharmacother,2013,14 ( 3 ) : 269 - 277.
  • 8A1-Tawil N. Pharmacokinetics of transdermal buprenorphine patch in the elderly [ J ]. Eur J Clin Pharmaco1,2013,69 (2) : 143 - 149.
  • 9Setti T, Sanfilippo F, Leykin Y. Transdermal buprenorphine for post- operative pain control in gynecological surgery: a prospective ran- domized study[ J ]. Curt Med Res Opin, 2012,28 ( 10 ) : 1597 - 1608.
  • 10Kapil RP. Once-Weekly Transdermal Buprenorphine Application Re- suits in Sustained and Consistent Steady-State Plasma Levels[ J]. J Pain Symptom Manage ,2012 : 188.

共引文献127

同被引文献11

  • 1柯光明,王丽,杜洪光,王树明,郭洪猷.高效液相色谱法测定盐酸利多卡因贴剂含量[J].北京化工大学学报(自然科学版),2004,31(5):110-112. 被引量:9
  • 2Gralla R,Lichinitser M,Van Der Vegt S,Sleeboom H,Mezger J,Peschel C,Tonini G,Labianca R,Macciocchi A,Aapro M.Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO . 2003
  • 3Hutt A J,Tan S C.Drug chirality and its clinical significance. Drugs . 1996
  • 4Eisenberg P,Figueroa-Vadillo J,Zamora R,et al.Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer . 2003
  • 5Eisenberg P,MacKintosh F R,Ritch P,Cornett P A,Macciocchi A.Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO . 2004
  • 6谢沐风.如何科学、客观地制订溶出度试验质量标准[J].中国医药工业杂志,2012,43(3). 被引量:125
  • 7王婴,王岩.青藤碱透皮贴剂的含量及释放度测定[J].中国实验方剂学杂志,2013,19(17):146-148. 被引量:2
  • 8杜丽娜,金义光.经皮给药系统研究进展[J].国际药学研究杂志,2013,40(4):379-385. 被引量:26
  • 9叶玉杰,李芳,任德全,张永忠,刘嵩.Origin软件拟合制剂体外释药规律的应用[J].数理医药学杂志,2014,27(1):93-94. 被引量:15
  • 10安佃云,贺亚静,张建芳,翁伟宇,李伟,沈腾,徐惠南.磷酸川芎嗪透皮贴含量均匀度及释放度测定[J].药物分析杂志,2014,34(11):2087-2090. 被引量:2

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部